Clay Thorp, Director, 10% Owner at PhaseBio Pharmaceuticals Inc (PHAS), sold 2,908 shares at $14.00 ($41K) on 2019-07-01, disclosed to the SEC on 2019-07-03.
Open-market sale of $41k PHAS by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.00 | 180 | $3K | 6.2% |
| 2 | $14.00 | 255 | $4K | 8.8% |
| 3 | $14.00 | 459 | $6K | 15.8% |
| 4 | $14.00 | 2,014 | $28K | 69.3% |
| Total | $14.00 avg | 2,908 | $41K | 100% |
| Filing → |
| CLSD | BUY | 2022-12-21 | $14K | — | Filing → |
| VIGL | BUY | 2022-05-17 | $165K | — | Filing → |
| VIGL | BUY | 2022-03-28 | $22K | — | Filing → |